Showing results (531-540 of 541) with videos related to
Sort By:
Pageof 55
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3Chuhui Huang, Si Si Liew, Grace R Lin, et al.EMBO Molecular Medicine|January 7, 2022
Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infectionMatthew Zirui Tay, Angeline Rouers, Siew-Wai Fong, et al.Journal of Medical Virology|October 28, 2022
Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boostersAngeline Rouers, Nathan Wong, Yun Shan Goh, et al.Clinical & Translational Immunology|August 26, 2022
Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccineYun Shan Goh, Siew-Wai Fong, Angeline Rouers, et al.Antioxidants & Redox Signaling|December 4, 2012
Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosineLars Barregard, Peter Møller, Trine Henriksen, et al.Nature Communications|August 8, 2022
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine doseLaurent Renia, Yun Shan Goh, Angeline Rouers, et al.Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 21, 2012
[Sulphasalazine in patients with rheumatoid arthritis in China: a cross-sectional study]Tian Liu, Xiu-ru Wang, Yuan An, et al.Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 21, 2012
[Survey of tumor necrosis factor inhibitors application in patients with rheumatoid arthritis in China]Xiu-ru Wang, Yin Su, Yuan An, et al.Chinese Medical Journal|August 31, 2012
Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in ChinaYue-Yun Lai, Xiao-Jun Huang, Zhen Cai, et al.Pageof 55